Last reviewed · How we verify

NCT04962568: SENNI

Ultrasonographic Evaluation of the Diaphragm During NHF Versus NIV Use in Respiratory Failure

Status unknown NA Last updated 31 March 2022
What this trial tests

NA trial testing DTEE in Diaphragm Issues in 35 participants. Status unknown.

Timeline
7 July 2021
Primary endpoint
7 August 2021
5 September 2022

Quick facts

Lead sponsorJens Bräunlich
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment35
Start date7 July 2021
Primary completion7 August 2021
Estimated completion5 September 2022
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Jens Bräunlich

Who can join

18 and older, any sex, with Diaphragm Issues or Respiratory Failure With Hypoxia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will describe influence of NHF or NIV to different ultrasonographic parameters of the diaphragm. Therefor subjects will be randomized to the sequence NHF and than NIV or NIV and than NHF. In all subjects same parameters will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diaphragm Issues

Currently open trials in the same condition.

Other Jens Bräunlich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04962568.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing